Items where authors include "Sullivan, W."

Article

Vadgama, S. orcid.org/0000-0002-9138-8471, Pasquini, M.C. orcid.org/0000-0003-1579-2293, Maziarz, R.T. orcid.org/0000-0002-8184-7099 et al. (7 more authors) (2024) “Don't keep me waiting”: estimating the impact of reduced vein-to-vein time on lifetime US 3L+ LBCL patient outcomes. Blood Advances, 8 (13). pp. 3519-3527. ISSN 2473-9529

Hart, R., Burns, D., Ramaekers, B. et al. (8 more authors) (2020) R and Shiny for cost-effectiveness analyses : why and when? A hypothetical case study. PharmacoEconomics, 38. pp. 765-776. ISSN 1170-7690

Proceedings Paper

Metry, A., Sullivan, W., Kearns, B.C. et al. (1 more author) (2019) Would a cohort-level approach to cost-effectiveness modelling have led to a different decision in an important nice appraisal for obesity patients? In: Value in Health. ISPOR Europe 2019, 02-07 Nov 2019, Copenhagen, Denmark. Elsevier , S577-S578.

Sullivan, W., Bullement, A. orcid.org/0000-0001-7091-0972 and Lee, D. (2018) Dice for NICE? Lessons from a single technology appraisal. In: Value in Health. ISPOR Europe 2018: New Perspectives for Improving 21st Century Health Systems, 10-14 Nov 2018, Barcelona, Spain. Elsevier , S379-S379.

Willis, A., Bullement, A. orcid.org/0000-0001-7091-0972 and Sullivan, W. (2018) Estimated cost savings from dose banding guidance: a case study using treatments for stage IV melanoma. In: Value in Health. ISPOR Europe 2018: New Perspectives for Improving 21st Century Health Systems, 10-14 Nov 2018, Barcelona, Spain. Elsevier , S378-S379.

Mahon, S., Bullement, A. orcid.org/0000-0001-7091-0972, Willis, A. et al. (5 more authors) (2017) PCN155 - Cost effectiveness of Nivolumab for patients with advanced, previously treated renal cell carcinoma in Scotland. In: Value in Health. ISPOR 20th Annual European Congress, 04-08 Nov 2017, Glasgow, Scotland. Elsevier , A440.